From NICHD patient to registered nurse. Kristal Nemeroff shares her story living with the genetic disorder, Osteogenesis Imperfecta.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Media Advisory: NIH researchers find a potential treatment for disorders involving excess red blood cells
Researchers at the National Institutes of Health have cured mice with Chuvash polycythemia, a life-threatening disorder that involves the overproduction of red blood cells, with the experimental drug, Tempol.The findings offer hope that Tempol or a similar drug may treat polycythemias that affect humans, such as mountain sickness—a serious blood complication experienced in low-oxygen, high-altitude settings.
Science Update: Maternal genetic material essential for embryo development, NIH-funded study suggests
A molecule containing genetic instructions passed on from the mother to the egg must be present for the fertilized egg to survive and develop into a normal embryo, according to results of an NICHD-funded zebrafish study.
Spotlight: Selected NICHD Research Advances of 2017
Over the past year, NICHD contributed to numerous scientific advances and key initiatives.
Spotlight: Zika Research after Hurricane Maria
Dr. Carmen Zorrilla, who leads NICHD’s Zika in Infants and Pregnancy (ZIP) study in Puerto Rico, reports on how Hurricane Maria affected the Island’s largest hospital in San Juan.
NIH-funded rehabilitation technologies receive FDA clearance
Devices bolster function and ability for people with disabilities or injuries.
NICHD Director Recognized with March of Dimes Lifetime Achievement Award
Dr. Diana W. Bianchi is recognized with the March of Dimes Colonel Harland Sanders Lifetime Achievement Award for significant contributions toward the prevention or treatment of birth defects and other genetic disorders.
No benefit in treating mildly low thyroid function in pregnancy, NIH Network study finds
There appears to be no benefit to treating mildly low thyroid function during pregnancy, according to a study by a National Institutes of Health research network.
NIH workshop identifies complex health problems among Zika-affected infants
Children exposed to Zika virus in the womb may face complex health and developmental problems as they grow older, according to discussions at an NIH workshop.
The Gabriella Miller Kids First Pediatric Research Program
NICHD participates in the Gabriella Miller Kids First Pediatric Research Program to support pediatric research and understand the link between pediatric cancers and structural birth defects.
Getting to Know the New NICHD Director
NICHD Director Dr. Diana Bianchi shares some thoughts about joining NICHD.
Even partial steroid treatment can benefit extremely preterm infants, NIH study suggests
Steroids improve survival and reduce the chances of certain complications for extremely premature infants, even if the treatment course is not finished before delivery, according to a study funded by the National Institutes of Health (NIH).
NIH to host scientific workshop on Zika virus and child development
NICHD will host a workshop on September 22-23, 2016 to identify the best approaches for treating and caring for children exposed to Zika virus in the womb. Participants from the United States, Brazil and Puerto Rico, who are experts in obstetrics, maternal and pediatric infectious diseases, child development, rehabilitation and vaccine research, will deliver lectures and lead panel discussions.
Zika from the Front Lines
NICHD's Nahida Chakhtoura, M.D., recently returned from Puerto Rico after visiting with NICHD-supported researchers who are studying Zika in pregnancy and fetal development. Read more about her trip, the research, and the women she met.
NIH funds Zika virus study involving U.S. Olympic team
Researchers supported by the National Institutes of Health will monitor potential Zika virus exposure among a subset of athletes, coaches and other U.S. Olympic Committee (USOC) staff attending the 2016 Summer Olympics and Paralympics in Brazil.
NIH Launches Large Study of Pregnant Women in Areas Affected by Zika Virus
The National Institutes of Health (NIH) and Fundacao Oswaldo Cruz-Fiocruz (Fiocruz) begin a multi-country study to evaluate the magnitude of health risks that Zika virus infection poses to pregnant women and their developing fetuses and infants.
Zika virus damages placenta, kills fetal mice
Zika virus infects and crosses the placentas of pregnant mice and causes severe damage or death in fetal mice, report scientists funded by the National Institutes of Health.
NICHD Begins Study in Brazil of Zika Virus Infection during Pregnancy
NICHD has launched an observational study of pregnant women in Brazil to help improve understanding of the effects of Zika virus infection on reproductive health and the developing fetus. The study augments an existing project in Brazil on cytomegalovirus (CMV) infection during pregnancy, expanding the project’s scope to include Zika virus.
NICHD researchers identify cause of rare disease, Smith-Lemli-Opitz syndrome
Smith-Lemli-Opitz syndrome, a rare genetic disease that disrupts the nervous system and can lead to microcephaly and other brain defects, appears to result from a buildup of a cholesterol precursor, according to a new study by NICHD researchers.
Prenatal exposure to marijuana may disrupt fetal brain development, mouse study suggests
Fetal mice exposed in the uterus to delta-9-tetrahydrocannabinol (THC), marijuana’s primary psychoactive ingredient, lose a key subset of neurons, according to a new study by NICHD researchers.
BACK TO TOP